Compare BIP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIP | SNN |
|---|---|---|
| Founded | 2007 | 1856 |
| Country | Bermuda | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Marine Transportation | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 14.3B |
| IPO Year | N/A | N/A |
| Metric | BIP | SNN |
|---|---|---|
| Price | $37.99 | $29.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $39.50 | $36.25 |
| AVG Volume (30 Days) | 901.6K | ★ 1.3M |
| Earning Date | 04-29-2026 | 03-16-2026 |
| Dividend Yield | ★ 5.23% | 2.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | $7.61 | $5.60 |
| P/E Ratio | ★ $39.22 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.63 | $28.23 |
| 52 Week High | $40.32 | $38.79 |
| Indicator | BIP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 60.52 | 36.48 |
| Support Level | $37.21 | N/A |
| Resistance Level | $40.09 | $33.89 |
| Average True Range (ATR) | 0.99 | 0.58 |
| MACD | 0.26 | -0.09 |
| Stochastic Oscillator | 83.27 | 17.70 |
Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.